XML 94 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Residential Mortgage Securities and MSR-Related Assets (Tables)
9 Months Ended
Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]  
Schedule of information about MBS and CRT Securities
The following tables present certain information about the Company’s residential mortgage securities at September 30, 2019 and December 31, 2018:
 
September 30, 2019
(In Thousands)
 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve and 
OTTI (1)
 
Amortized
Cost (2)
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Fair Value
Agency MBS: (3)
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fannie Mae
 
$
1,217,508

 
$
46,917

 
$
(23
)
 
$

 
$
1,264,402

 
$
10,896

 
$
(15,282
)
 
$
(4,386
)
 
$
1,260,016

Freddie Mac
 
526,173

 
21,303

 

 

 
548,441

 
5,159

 
(3,990
)
 
1,169

 
549,610

Ginnie Mae
 
4,118

 
76

 

 

 
4,194

 
53

 

 
53

 
4,247

Total Agency MBS
 
1,747,799

 
68,296

 
(23
)
 

 
1,817,037

 
16,108

 
(19,272
)
 
(3,164
)
 
1,813,873

Non-Agency MBS:
 
 

 
 

 
 

 
 

 
 
 
 

 
 

 
 

 
 

Expected to Recover Par (4)(5)
 
917,981

 

 
(14,176
)
 

 
903,805

 
17,905

 
(5
)
 
17,900

 
921,705

Expected to Recover Less than Par (4)
 
1,611,768

 

 
(88,121
)
 
(462,095
)
 
1,061,552

 
414,788

 
(256
)
 
414,532

 
1,476,084

Total Non-Agency MBS (6)
 
2,529,749

 

 
(102,297
)
 
(462,095
)
 
1,965,357

 
432,693

 
(261
)
 
432,432

 
2,397,789

Total MBS
 
4,277,548

 
68,296

 
(102,320
)
 
(462,095
)
 
3,782,394

 
448,801

 
(19,533
)
 
429,268

 
4,211,662

CRT securities (7)
 
364,284

 
5,882

 
(117
)
 

 
370,049

 
8,084

 
(241
)
 
7,843

 
377,892

Total MBS and CRT securities
 
$
4,641,832

 
$
74,178

 
$
(102,437
)
 
$
(462,095
)
 
$
4,152,443

 
$
456,885

 
$
(19,774
)
 
$
437,111

 
$
4,589,554


December 31, 2018
(In Thousands)
 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve and 
OTTI (1)
 
Amortized
Cost (2)
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Fair Value
Agency MBS: (3)
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fannie Mae
 
$
1,716,340

 
$
65,930

 
$
(24
)
 
$

 
$
1,782,246

 
$
12,107

 
$
(32,321
)
 
$
(20,214
)
 
$
1,762,032

Freddie Mac
 
909,561

 
36,991

 

 

 
947,588

 
907

 
(17,177
)
 
(16,270
)
 
931,318

Ginnie Mae
 
4,729

 
87

 

 

 
4,816

 
47

 

 
47

 
4,863

Total Agency MBS
 
2,630,630

 
103,008

 
(24
)
 

 
2,734,650

 
13,061

 
(49,498
)
 
(36,437
)
 
2,698,213

Non-Agency MBS:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected to Recover Par (4)(5)
 
1,536,485

 
40

 
(21,725
)
 

 
1,514,800

 
20,520

 
(7,620
)
 
12,900

 
1,527,700

Expected to Recover Less than Par (4)
 
2,002,319

 

 
(133,300
)
 
(516,116
)
 
1,352,903

 
438,465

 
(769
)
 
437,696

 
1,790,599

Total Non-Agency MBS (6)
 
3,538,804

 
40

 
(155,025
)
 
(516,116
)
 
2,867,703

 
458,985

 
(8,389
)
 
450,596

 
3,318,299

Total MBS
 
6,169,434

 
103,048

 
(155,049
)
 
(516,116
)
 
5,602,353

 
472,046

 
(57,887
)
 
414,159

 
6,016,512

CRT securities (7)
 
476,744

 
9,321

 
107

 

 
486,172

 
12,545

 
(5,896
)
 
6,649

 
492,821

Total MBS and CRT securities
 
$
6,646,178

 
$
112,369

 
$
(154,942
)
 
$
(516,116
)
 
$
6,088,525

 
$
484,591

 
$
(63,783
)
 
$
420,808

 
$
6,509,333

 
(1)
Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income.  Amounts disclosed at September 30, 2019 reflect Credit Reserve of $451.1 million and OTTI of $11.0 million.  Amounts disclosed at December 31, 2018 reflect Credit Reserve of $503.3 million and OTTI of $12.8 million.
(2)
Includes principal payments receivable of $965,000 and $1.0 million at September 30, 2019 and December 31, 2018, respectively, which are not included in the Principal/Current Face.
(3)
Amounts disclosed at September 30, 2019 and December 31, 2018 include Agency MBS with a fair value of $312.5 million and $736.5 million, respectively, for which the fair value option has been elected. Such securities had gross unrealized gains of $4.1 million and no unrealized losses at September 30, 2019, and no unrealized gains and gross unrealized losses of approximately $3.3 million at December 31, 2018, respectively.
(4)
Based on managements current estimates of future principal cash flows expected to be received.
(5)
Includes RPL/NPL MBS, which at September 30, 2019 had an $824.8 million Principal/Current face, $824.3 million amortized cost and $828.1 million fair value. At December 31, 2018, RPL/NPL MBS had a $1.4 billion Principal/Current face, $1.4 billion amortized cost and $1.4 billion fair value.
(6)
At September 30, 2019 and December 31, 2018, the Company expected to recover approximately 82% and 85% of the then-current face amount of Non-Agency MBS, respectively.
(7)
Amounts disclosed at September 30, 2019 includes CRT securities with a fair value of $351.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $7.8 million and gross unrealized losses of approximately $0.2 million at September 30, 2019. Amounts disclosed at December 31, 2018 includes CRT securities with a fair value of $477.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $12.5 million and gross unrealized losses of approximately $5.6 million at December 31, 2018.
Schedule of Sale of Residential Mortgage Securities
The following tables present information about the Company’s sales of its residential mortgage securities for the three and nine months ended September 30, 2019 and 2018. The Company has no continuing involvement with any of the sold MBS.

 
 
Three Months Ended
September 30, 2019
 
Three Months Ended
September 30, 2018
(In Thousands)
 
Sales Proceeds
 
Gains/(Losses)
 
Sales Proceeds
 
Gains/(Losses)
Agency MBS
 
$
257,289

 
$
2,771

 
$

 
$

Non-Agency MBS
 
47,867

 
14,444

 
24,341

 
3,391

CRT Securities
 
28,969

 
493

 
118,855

 
13,024

Total
 
$
334,125

 
$
17,708

 
$
143,196

 
$
16,415


 
 
Nine Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2018
(In Thousands)
 
Sales Proceeds
 
Gains/(Losses)
 
Sales Proceeds
 
Gains/(Losses)
Agency MBS
 
$
360,634

 
$
499

 
$
75,306

 
$
(3,787
)
Non-Agency MBS
 
244,778

 
41,420

 
43,703

 
12,208

CRT Securities
 
133,507

 
8,108

 
222,877

 
24,240

Total
 
$
738,919

 
$
50,027

 
$
341,886

 
$
32,661


Schedule of information about MBS and CRT Securities that were in an unrealized loss position
The following table presents information about the Company’s residential mortgage securities that were in an unrealized loss position at September 30, 2019:
 
Unrealized Loss Position For:
 
 
Less than 12 Months
 
12 Months or more
 
Total
 
Fair Value
 
Unrealized Losses
 
Number of Securities
Fair Value
 
Unrealized Losses
 
Number of Securities
Fair Value
 
Unrealized Losses
(Dollars in Thousands)
Agency MBS: 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fannie Mae
 
$
36,775

 
$
104

 
25

 
$
660,757

 
$
15,178

 
280

 
$
697,532

 
$
15,282

Freddie Mac
 

 

 

 
163,863

 
3,990

 
101

 
163,863

 
3,990

Ginnie Mae
 

 

 

 
172

 

 
1

 
172

 

Total Agency MBS
 
36,775

 
104

 
25

 
824,792

 
19,168

 
382

 
861,567

 
19,272

Non-Agency MBS:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Expected to Recover Par (1)
 

 

 

 
7,495

 
5

 
1

 
7,495

 
5

Expected to Recover Less than Par (1)
 
2,009

 
11

 
1

 
1,894

 
245

 
2

 
3,903

 
256

Total Non-Agency MBS
 
2,009

 
11

 
1

 
9,389

 
250

 
3

 
11,398

 
261

Total MBS
 
38,784

 
115

 
26

 
834,181

 
19,418

 
385

 
872,965

 
19,533

CRT securities (2)
 
7,189

 
41

 
2

 
24,966

 
200

 
7

 
32,155

 
241

Total MBS and CRT securities
 
$
45,973

 
$
156

 
28

 
$
859,147

 
$
19,618

 
392

 
$
905,120

 
$
19,774



(1)
Based on management’s current estimates of future principal cash flows expected to be received.
(2)
Amounts disclosed at September 30, 2019 include CRT securities with a fair value of $32.2 million for which the fair value option has been elected. Such securities had unrealized losses of $241,000 at September 30, 2019.

Schedule of changes in credit loss component of OTTI
The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.
 
 
 
Three Months Ended
September 30, 2019
 
Nine months ended September 30, 2019
(In Thousands)
 
 
Credit loss component of OTTI at beginning of period
 
$
39,596

 
$
39,596

Additions for credit related OTTI not previously recognized
 

 

Subsequent additional credit related OTTI recorded
 

 

Credit loss component of OTTI at end of period
 
$
39,596

 
$
39,596



Schedule of changes in the components of the purchase discount on Non-Agency MBS
The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three and nine months ended September 30, 2019 and 2018:

 
 
Three Months Ended
September 30, 2019
 
Three Months Ended
September 30, 2018
(In Thousands)
 
Discount
Designated as
Credit Reserve and OTTI
 
Accretable
Discount
(1) 
Discount
Designated as
Credit Reserve and OTTI
 
 Accretable Discount (1)
Balance at beginning of period
 
$
(479,566
)
 
$
(117,753
)
 
$
(553,596
)
 
$
(202,248
)
Impact of RMBS Issuer Settlement (2)
 

 

 

 
(2,734
)
Accretion of discount
 

 
10,357

 

 
20,115

Realized credit losses
 
4,062

 

 
12,042

 

Purchases
 

 

 
(1,975
)
 
1,368

Sales
 
12,479

 
6,029

 
1,552

 
1,974

Transfers/release of credit reserve
 
930

 
(930
)
 
10,220

 
(10,220
)
Balance at end of period
 
$
(462,095
)
 
$
(102,297
)
 
$
(531,757
)
 
$
(191,745
)

 
 
Nine Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2018
(In Thousands)
 
Discount
Designated as
Credit Reserve and OTTI
 
Accretable
Discount (1) 
Discount
Designated as
Credit Reserve and OTTI
 
 Accretable Discount (1)
Balance at beginning of period
 
$
(516,116
)
 
$
(155,025
)
 
$
(593,227
)
 
$
(215,325
)
Impact of RMBS Issuer Settlement (2)(3)
 

 
(1,688
)
 

 
(14,822
)
Accretion of discount
 

 
38,215

 

 
54,860

Realized credit losses
 
21,482

 

 
31,443

 

Purchases
 
(624
)
 
291

 
(2,510
)
 
1,856

Sales
 
23,842

 
25,231

 
7,144

 
7,079

Transfers/release of credit reserve
 
9,321

 
(9,321
)
 
25,393

 
(25,393
)
Balance at end of period
 
$
(462,095
)
 
$
(102,297
)
 
$
(531,757
)
 
$
(191,745
)


(1)
Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
(2)
Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc.
(3)
Includes the impact of cash proceeds (a one-time payment) received by the Company in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities of approximately $1.7 million during the nine months ended September 30, 2019 and approximately $12.1 million during the nine months ended September 30, 2018.
Schedule of impact of AFS on AOCI
The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2019 and 2018:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(In Thousands)
2019
 
2018
 
2019
 
2018
AOCI from AFS securities:
 
 

 
 

 
 

 
 

Unrealized gain on AFS securities at beginning of period
 
$
439,898

 
$
548,551

 
$
417,167

 
$
620,648

Unrealized gain/(loss) on Agency MBS, net
 
603

 
(9,177
)
 
22,483

 
(27,507
)
Unrealized gain/(loss) on Non-Agency MBS, net
 
2,856

 
(25,101
)
 
22,211

 
(62,979
)
Unrealized gain on MSR term notes, net
 
2,024

 

 
5,391

 
236

Reclassification adjustment for MBS sales included in net income
 
(14,499
)
 
(9,455
)
 
(36,370
)
 
(25,580
)
Change in AOCI from AFS securities
 
(9,016
)
 
(43,733
)
 
13,715

 
(115,830
)
Balance at end of period
 
$
430,882

 
$
504,818

 
$
430,882

 
$
504,818


Schedule of interest income on MBS, CRT Securities and MSR Related Assets
The following table presents the components of interest income on the Company’s residential mortgage securities and MSR- related assets for the three and nine months ended September 30, 2019 and 2018
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(In Thousands)
 
2019
 
2018
 
2019
 
2018
Agency MBS
 
 
 
 
 
 
 
 
Coupon interest
 
$
18,994

 
$
21,549

 
$
66,560

 
$
62,546

Effective yield adjustment (1)
 
(7,188
)
 
(7,217
)
 
(21,039
)
 
(19,751
)
Interest income
 
$
11,806

 
$
14,332

 
$
45,521

 
$
42,795

 
 
 
 
 
 
 
 
 
Legacy Non-Agency MBS
 
 
 
 
 
 
 
 
Coupon interest
 
$
21,011

 
$
27,026

 
$
68,144

 
$
83,791

Effective yield adjustment (2)(3)
 
10,336

 
18,984

 
38,003

 
53,648

Interest income
 
$
31,347

 
$
46,010

 
$
106,147

 
$
137,439

 
 
 
 
 
 
 
 
 
RPL/NPL MBS
 
 
 
 
 
 
 
 
Coupon interest
 
$
13,227

 
$
11,526

 
$
44,305

 
$
31,167

Effective yield adjustment (1)(4)
 
8

 
1,131

 
158

 
1,206

Interest income
 
$
13,235

 
$
12,657

 
$
44,463

 
$
32,373

 
 
 
 
 
 
 
 
 
CRT securities
 
 
 
 
 
 
 
 
Coupon interest
 
$
5,174

 
$
7,257

 
$
16,769

 
$
23,484

Effective yield adjustment (2)
 
(923
)
 
491

 
(1,224
)
 
2,455

Interest income
 
$
4,251

 
$
7,748

 
$
15,545

 
$
25,939

 
 
 
 
 
 
 
 
 
MSR-related assets
 
 
 
 
 
 
 
 
Coupon interest
 
$
15,222

 
$
6,387

 
$
38,107

 
$
18,985

Effective yield adjustment (1)
 
52

 
20

 
125

 
1,264

Interest income
 
$
15,274

 
$
6,407

 
$
38,232

 
$
20,249

 
(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.
(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.
(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $2.3 million during the three months ended September 30, 2018, and $3.1 million and $2.3 million during the nine months ended September 30, 2019 and 2018, respectively.
(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $4,000 and $1.1 million during the three months ended September 30, 2019 and 2018, respectively, and $152,000 and $1.2 million during the nine months ended September 30, 2019 and 2018, respectively.